Company: ABBV
Filing Date: 2025-03-24
Form Type: DEF 14A
Source: 0001558370-25-003537
Chunk: 83

Company: AbbVie Inc.
Filing Date: 2025-03-24
Form: DEF 14A
Chunk 83
---
 auditor. Although the audit committee has sole authority to appoint the independent auditor, it would like to know the opinion of the stockholders regarding its appointment of Ernst & Young LLP for 2025. For this reason, stockholders are being asked to ratify this appointment. If the stockholders do not ratify the appointment of Ernst & Young LLP for 2025, the audit committee will take that fact into consideration, but may, nevertheless, continue to retain Ernst & Young LLP. The audit committee and the Board believe that the continued retention of Ernst & Young LLP to serve as the company’s independent auditor is in the best interests of the company and its stockholders. Representatives of Ernst & Young LLP are expected to attend the Annual Meeting and will be given the opportunity to make a statement if they desire to do so. They will also be available to respond to appropriate questions.

72 | 2025 Proxy Statement

AUDIT INFORMATION Audit Fees and Non-Audit Fees The following table presents fees for professional audit services rendered to AbbVie by Ernst & Young LLP for the years ended December 31, 2024 and December 31, 2023, and fees for other services rendered to AbbVie by Ernst & Young LLP for those periods.

| ​                      
 ​                      
 ​                      | ​ 
 ​ | ​          
 2024       
 (millions) |    ​ | ​ 
 ​ | ​          
 2023       
 (millions) |    ​ |
|:-----------------------|:--|:-----------|-----:|:--|:-----------|-----:|
| Audit fees:(1)         | ​ | $          | 20.6 | ​ | $          | 19.7 |
| Audit related fees:(2) | ​ |            |  0.7 | ​ |            |  0.5 |
| Tax fees:(3)           | ​ |            |  4.2 | ​ |            |  3.4 |
| Other fees:(4)         | ​ |            |  0.0 | ​ |            |  0.4 |
| Total                  | ​ | $          | 25.5 | ​ | $          | 24.0 |

| (1) | Ernst & Young LLP billed or will bill AbbVie for professional services rendered for the audit of AbbVie’s annual financial statements, the review of AbbVie’s financial statements included in AbbVie’s quarterly reports, the audits of AbbVie’s internal